Kolesnikov-Gauthier Hélène, Leblond Pierre, Rocourt Nathalie, Carpentier Philippe
Centre Oscar-Lambret, services de médecine nucléaire, 3, avenue Combemale, BP 307, 59020 Lille Cedex, France.
Bull Cancer. 2011 May;98(5):501-14. doi: 10.1684/bdc.2011.1354.
FDG-PET has boomed in recent years for diagnosis, staging and the search for recurrence of a large number of tumors. This is particularly true for soft tissue sarcomas and musculoskeletal sarcomas, for which the first publications on the potential role of FDG-PET dating back to the early 1990s. The majority of published studies on adult sarcomas confer, possibly a mixed population. Studies dedicated to pediatrics population are much rarer. The "Standards, Options and Recommendations" of the French Federation of Anticancer Centers published in 2003 on "The use of FDG-PET in oncology" and make recommendations and expert advices as part sarcomas of adult patients. After a first part dedicated to the particular interpretation of FDG PET in children, the purpose of this paper is to review the potential contribution of this exam in the treatment of pediatric sarcomas.
近年来，氟代脱氧葡萄糖正电子发射断层扫描（FDG-PET）在大量肿瘤的诊断、分期及复发检测方面得到了蓬勃发展。对于软组织肉瘤和肌肉骨骼肉瘤而言尤其如此，关于FDG-PET潜在作用的首批出版物可追溯到20世纪90年代初。大多数已发表的关于成人肉瘤的研究涵盖了可能是混合的人群。针对儿科人群的研究则更为罕见。法国抗癌中心联合会于2003年发表的“肿瘤学中FDG-PET的使用”的“标准、选项和建议”，并给出了针对成年患者肉瘤部分的建议和专家意见。在第一部分专门阐述了儿童FDG PET的特殊解读之后，本文的目的是回顾这项检查在儿科肉瘤治疗中的潜在贡献。
